VEC.L Share News (VEC)

20 Jan 2014

LONDON (Alliance News) - Vectura Group PLC said Monday that its partner Sandoz has launched its AirFluSal Forspiro asthma inhaler in Denmark. AirFluSa...

16 Jan 2014

LONDON (Alliance News) - Vectura Group PLC said Thursday that its partner Sandoz, part of Novartis AG, has received marketing authorisation for its Ai...

14 Jan 2014

Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks. At the JP Morgan He...

14 Jan 2014

Vectura, the AIM-listed respiratory development company, confirmed that its partner Sandoz, has received Swedish marketing authorisation for AirFluSal...

14 Jan 2014

LONDON, Jan 14 (Reuters) - Sweden has followed Denmark and Germany in approving the sale of a generic copy of GlaxoSmithKline's $8 billion-a-year inha...

14 Jan 2014

LONDON (Alliance News) - Vectura Group PLC said Tuesday that its partner Sandoz has received marketing authorisation for its AirFluSal Forspira inhale...

13 Jan 2014

LONDON, Jan 13 (Reuters) - Germany approved the sale of a generic version of GlaxoSmithKline's Advair on Monday, becoming the second country in Europe...

19 Dec 2013

AstraZeneca: Alphavalue lowers target price from 3169p to 3087.7p and downgrades from reduce to sell. British American Tabacco: Panmure Gordon reduce...